These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 2008794)
1. Relationship between tranylcypromine sulfate dose and monoamine oxidase inhibition. Grasso RA; Perry PJ; Sherman AD DICP; 1991 Jan; 25(1):99-100. PubMed ID: 2008794 [No Abstract] [Full Text] [Related]
2. Loss of antidepressant effect with long-term monoamine oxidase inhibitor treatment without loss of monoamine oxidase inhibition. Mann JJ J Clin Psychopharmacol; 1983 Dec; 3(6):363-6. PubMed ID: 6315778 [No Abstract] [Full Text] [Related]
3. Monoamine oxidase inhibitors revisited: what you should know. Goldberg JF; Thase ME J Clin Psychiatry; 2013 Feb; 74(2):189-91. PubMed ID: 23473352 [No Abstract] [Full Text] [Related]
4. Stroke resulting from a rapid switch from phenelzine to tranylcypromine. Mattes JA J Clin Psychiatry; 1998 Jul; 59(7):382. PubMed ID: 9714269 [No Abstract] [Full Text] [Related]
5. Tranylcypromine and inhibition of MAO activity. Bowden CL J Clin Psychopharmacol; 1984 Jun; 4(3):172-3. PubMed ID: 6736280 [No Abstract] [Full Text] [Related]
6. Refractory depression treated with high doses of monoamine oxidase inhibitor. Guze BH; Baxter LR; Rego J J Clin Psychiatry; 1987 Jan; 48(1):31-2. PubMed ID: 3804984 [TBL] [Abstract][Full Text] [Related]
7. Effects of drugs on human blood platelet and plasma amine oxidase activity in vitro and in vivo. Robinson DS; Lovenberg W; Keiser H; Sjoerdsma A Biochem Pharmacol; 1968 Jan; 17(1):109-19. PubMed ID: 4384242 [No Abstract] [Full Text] [Related]
9. Effect of inhibitors of monoamine oxidase on various enzymes and on the storage of monoamines. GEY KF; PLETSCHER A; BURKARD W Ann N Y Acad Sci; 1963 Jul; 107():1147-51. PubMed ID: 13947443 [No Abstract] [Full Text] [Related]
10. Continuation and maintenance treatments in major depression: the neglected role of monoamine oxidase inhibitors. Kennedy SH J Psychiatry Neurosci; 1997 Mar; 22(2):127-31. PubMed ID: 9074307 [TBL] [Abstract][Full Text] [Related]
11. Implications of the platelet monoamine oxidase deficit during migraine attacks. Sandler M Res Clin Stud Headache; 1978; 6():65-72. PubMed ID: 725258 [No Abstract] [Full Text] [Related]
12. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors. Alemany R; Olmos G; García-Sevilla JA Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544 [TBL] [Abstract][Full Text] [Related]
13. Treatment of hyperactive children with monoamine oxidase inhibitors. I. Clinical efficacy. Zametkin A; Rapoport JL; Murphy DL; Linnoila M; Ismond D Arch Gen Psychiatry; 1985 Oct; 42(10):962-6. PubMed ID: 3899047 [TBL] [Abstract][Full Text] [Related]
14. Reversibility of MAO inhibition. Baxter LR J Clin Psychiatry; 1984 May; 45(5):234. PubMed ID: 6725215 [No Abstract] [Full Text] [Related]
15. [ELECTROENCEPHALOGRAPHIC CONTRIBUTION TO THE STUDY OF MONOAMINE OXIDASE INHIBITING DRUGS: CHANGES INDUCED IN EXPERIMENTAL EPILEPSY IN RABBITS]. LUCIONI R; PENATI G; INVERNIZZI G Riv Neurol; 1964; 34():368-74. PubMed ID: 14208879 [No Abstract] [Full Text] [Related]
16. [Effect of iprazid and transamine on monoamine oxidase activity and monoamine content on the brain of dogs and rabbits]. Kocherga VI; Gotovtseva EP Ukr Biokhim Zh; 1967; 39(2):125-9. PubMed ID: 5603055 [No Abstract] [Full Text] [Related]
17. MAO inhibition as antidepressive mechanism reevaluated. A controlled study with tranylcypromine isomers. Beckmann H; Moises HW Mod Probl Pharmacopsychiatry; 1983; 19():211-4. PubMed ID: 6865965 [No Abstract] [Full Text] [Related]
18. Comparison of five clinically used inhibitors of monoamine oxidase using the fluorescence microscopy method. Bartonícek V Med Pharmacol Exp Int J Exp Med; 1967; 16(2):142-6. PubMed ID: 5298397 [No Abstract] [Full Text] [Related]